Tissue Regenix Group plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.
.png "TRX - Hardman Co - Turning profitable and cash-generative (05.04.23)")
Investor Access
05
Sep
Event information
The Company will announce its interim results for the six months ended 30 June 2023 on Tuesday 5 September 2023 at 16:30 BST.
Investors can sign up to Investor Meet Company for free and add to meet Tissue Regenix Group via the following link:
https://www.investormeetcompany.com/tissue-regenix-group-plc/register-investorVenue
Online
Time
Tuesday 5 September 2023 at 16:30 BST
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | June |
| Interim Results* | 5 September |
| AGM* | June |
* Months based on previous announcements of this kind
